Press Release

Parkinson’s Disease Drugs Market 2026 Global Industry Share, Future Growth, Trends, Overview and Forecast 2026

Parkinson's Disease Drugs Market 2020 Global Top Key Players, Emerging Size, Growth Factor, Share- Novartis, Orion Pharma Ltd, ACADIA Pharmaceuticals Inc.

The global Parkinson’s disease drugs market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson’s disease. According to a report published by Fortune Business Insights, titled “Parkinson’s Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby exhibiting a CAGR of 8.1%. Increasing usage approvals are contributing to the growth of the global Parkinson’s disease drugs market. The Food and Drug Administration recently cleared two new drugs for the treatment of Parkinson’s disease. The drug approvals for Rytary and Duopa will emerge as breakthroughs in the healthcare industry.

Leading Players operating in the Parkinson’s Disease Drugs Market are:

 

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

 

  • Pfizer, Inc.
  • Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Novartis
  • Orion Pharma Ltd
  • UCB S.A
  • Teva Pharmaceutical Industries Ltd.
  • Vertical Pharmaceuticals, LLC
  • ACADIA Pharmaceuticals Inc.
  • Impax Laboratories, Inc.
  • Lundbeck A/S.

Detailed Table of Content:

 

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Prevalence of Parkinson’s Disease – For Key Countreis, 2018
    • Regulatory Scenario – For Key Countries
    • Patent Snapshot
    • New Product Launch
    • Pipeline Analysis
    • Key Industry Developments – Mergers, Acquisitions and Partnerships
  • Global Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Decarboxylase Inhibitors
      • Dopamine Agonists
      • Monoamine Oxidase Type B (MAO-B) Inhibitors
      • Catechol-O-Methyltransferase (COMT) Inhibitors
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Injection
      • Transdermal
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Stores
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • North America Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
      • Key Findings / Summary
      • Market Analysis – By Drug Class
        • Decarboxylase Inhibitors
        • Dopamine Agonists
        • Monoamine Oxidase Type B (MAO-B) Inhibitors
        • Catechol-O-Methyltransferase (COMT) Inhibitors
        • Others
      • Market Analysis – By Route of Administration
        • Oral
        • Injection
        • Transdermal
      • Market Analysis – By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Stores
      • Market Analysis – By Country
        • S.
        • Canada

Related Reports: 

Why Dental Implants Market Trending in 2020? Know The Forecast Research till 2026

Why Hiv Drugs Market Trending in 2020? Know The Forecast Research till 2026

Why Blood Glucose Monitoring Systems Market Trending in 2020? Know The Forecast Research till 2026

 

 

Show More

Betti Stone

Hi, let me cordially welcome you to medical market news. I am Bettie, the chief editor of the website. I have gathered years of experiencing in this website and not only experience but also memories. I have to manage the dynamic editorial team and oversee all strategy and content initiatives. Though I love my job a lot sometimes, I even enjoy the fresh air outside and hence take a walk during a break and re-energise myself.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close